This is a collaborate study done with the Renal Division, Department of Medicine, Faculty of Medicine,…
Category: Studies
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals
This study will evaluate the potential drug-drug interactions between dolutegravir (DTG) and steady state rifapentine (RPT)…
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)
A Phase 3, open-label, multicenter trial with a cluster-randomized superiority design (eligible contacts in the same…
Prospective Multicentre Evaluation of the Accuracy and Diagnostic Yield of the Fujifilm SILVAMP TB LAM (FujiLAM) Test for the Diagnosis of Tuberculosis in People Living With HIV
This is a prospective, multi centre cohort study in which the accuracy and the diagnostic yield…
Pilot Study for Development of Microneedles for Diagnosis of Latent Tuberculosis Infection
The cross-sectional study to investigate the effect of microneedle formulations and lengths of Tuberculin PPD microneedles…
Performance evaluation of Fujifilm SILVAMP TB LAM compared to Alere Determine™ TB LAM Antigen (Ag) for the detection of tuberculosis in children, adolescent and adult living with and without HIV in Thailand
A novel urine-based assay was co-developed by FIND and Fujifilm; the Fujifilm SILVAMP TB LAM (Fuji…
Efficacy, safety and pharmacokinetics of Dolutegravir 50 mg once daily with food versus Dolutegravir 50 mg twice daily in HIV/TB co-infected patients receiving rifampin-based anti-tuberculosis therapy
This is a stage II, randomized, open-label study describing the efficacy and safety of DTG 50…
A phase 2/3, multicenter, open-label, multicohort study evaluating pharmacokinetics (PK), safety, and efficacy of cobicistat-boosted Atazanavir (ATV/co) or cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 infected, virologically suppressed pediatric participants
This study assessed the safety and efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and…
A Phase 2 Study of BIT225, an Human Immunodeficiency Virus-1 (HIV-1) Vpu Inhibitor, in Treatment Naive HIV 1 Infected Individuals Commencing Dolutegravir-based Combination Antiretroviral Therapy (cART): Evaluation of Safety, Efficacy and Inflammatory and Immune Activation Markers
The proposed study will determine the potential efficacy and safety of a first-in-class HIV-1 Vpu inhibitor,…
A Phase 1b, Open-label study to Evaluate the PK, Safety and Efficacy of B/F/TAF in HIV-1 infected, Virologically Suppressed, Pregnant Women in their Second and Third Trimesters
The primary objective of this study is to evaluate the steady state pharmacokinetics of bictegravir (BIC)…
